Quarterly Transactions Made in Atossa Therapeutics, Inc. (ATOS)
This table provides information about the institutional ownership of Atossa Therapeutics, Inc. (ATOS). The information is specifically focused on institutions that hold shares of ATOSSA THERAPEUTICS, INC..
Shares Purchased
Shares Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2021 | 4,132,352 | 2,424,772 | 6,557,124 | 5,907,959 | 3,342,692 | 9,250,651 | -2,693,527 | |
Q4 2021 | 8,569,439 | 2,073,761 | 10,643,200 | 1,188,651 | 1,184,516 | 2,373,167 | 8,270,033 | |
Q1 2022 | 1,701,639 | 589,718 | 2,291,357 | 4,807,060 | 868,176 | 5,675,236 | -3,383,879 | |
Q2 2022 | 413,231 | 3,425,330 | 3,838,561 | 14,615,249 | 2,986,063 | 17,601,312 | -13,762,751 | |
Q3 2022 | 100,982 | 199,415 | 300,397 | 3,845,416 | 0 | 3,845,416 | -3,545,019 | |
Q4 2022 | 267,590 | 467,369 | 734,959 | 1,020,358 | 6 | 1,020,364 | -285,405 | |
Q1 2023 | 135,287 | 152,700 | 287,987 | 1,380,358 | 0 | 1,380,358 | -1,092,371 | |
Q2 2023 | 506,964 | 561,998 | 1,068,962 | 1,279,566 | 0 | 1,279,566 | -210,604 | |
Q3 2023 | 528,830 | 263,473 | 792,303 | 277,443 | 0 | 277,443 | 514,860 | |
Q4 2023 | 173,476 | 445,765 | 619,241 | 1,132,407 | 0 | 1,132,407 | -513,166 | |
Q1 2024 | 3,502,090 | 1,916,934 | 5,419,024 | 221,690 | 0 | 221,690 | 5,197,334 | |
Q2 2024 | 11,214,558 | 833,269 | 12,047,827 | 2,529,443 | 0 | 2,529,443 | 9,518,384 | |
Q3 2024 | 1,473,878 | 317,926 | 1,791,804 | 819,528 | 0 | 819,528 | 972,276 |